Berrien-Elliott, Melissa M <br/><br/>
Durable adoptive immunotherapy for leukemia produced by manipulation of multiple regulatory pathways of CD8+ T-cell tolerance.  [electronic resource] 

 -  Cancer research  Jan 2013 
 - 605-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-12-2179  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD--metabolism<br/>CD8-Positive T-Lymphocytes--immunology<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Cell Differentiation<br/>Cell Line, Tumor<br/>Immune Tolerance<br/>Immunotherapy, Adoptive<br/>Mice<br/>Mice, Transgenic<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Tumor Escape<br/>Lymphocyte Activation Gene 3 Protein